Ironwood pharmaceuticals boston
WebFeb 13, 2024 · BOSTON-- ( BUSINESS WIRE )-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental New Drug Application (sNDA) for LINZESS ® (linaclotide) for the treatment of children and adolescents ages 6 … WebIronwood Pharmaceuticals. Ironwood is dedicated to advancing the treatment of GI diseases and redefining the standard of care for millions of GI patients. Industry …
Ironwood pharmaceuticals boston
Did you know?
WebFeb 2, 2024 · Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts. We routinely post information that may be important to investors on our website at www.ironwoodpharma.com. In addition, follow us on Twitter and on LinkedIn . Investors: Greg Martini, 617-374-5230 [email protected] Matt Roache, 617 … WebApr 15, 2024 · Ironwood Pharmaceuticals Company Profile . Ironwood Pharmaceuticals, Inc is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA. …
WebApr 10, 2024 · Ironwood Pharmaceuticals Trading Up 3.1 %. Shares of NASDAQ:IRWD opened at $10.88 on Monday. The firm’s 50 day moving average is $11.01 and its two-hundred day moving average is $11.23. WebIronwood Pharmaceuticals’ fellowship programs are designed to offer Doctor of Pharmacy (PharmD) graduates in-depth experience within a biopharmaceutical setting through one of two unique experiences: A Medical Scientific Affairs and Clinical Development (MSA/CD) fellowship or a Global Patient Safety and Regulatory Affairs (GPS/RA) fellowship.
WebAug 26, 2024 · BOSTON-- (BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) approved a revised label for LINZESS ® (linaclotide) based on clinical safety data that has been generated thus far in pediatric studies. WebAug 3, 2024 · BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced the appointment of John Minardo as senior vice president, chief legal officer. Mr. Minardo will become a member of Ironwood's Leadership Team and oversee the company's Corporate Legal, Compliance …
WebPrior to Cyclerion, Todd was a co-founder of Ironwood Pharmaceuticals where he held a number of scientific program and functional leadership roles, including leading sGC stimulator discovery and early development efforts at Ironwood. ... From 2007 to 2011, she served as senior vice president of administration and general counsel for Boston ...
WebAddress: 100 Summer St Ste 2300 Boston, MA, 02110-2156 United States See other locations Phone: Website: www.ironwoodpharma.com Employees (this site): Modelled Employees (all sites): Actual Revenue: $410.60 million Actual Sales Growth: -0.76% Net Income Growth: -66.87% Assets: $1,100 Fiscal Year End: DEC Year Started: Incorporated: dialect englishWebJun 13, 2024 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced that the company … cinnamon tree rentalsWebMar 26, 2024 · BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today provided an update on certain impacts of COVID-19 on its business and the actions it ... dialecten in frieslandWebApr 12, 2024 · Shares of IRWD opened at $10.77 on Wednesday. Ironwood Pharmaceuticals, Inc. has a 1 year low of $9.73 and a 1 year high of $12.66. The company has a market cap of $1.66 billion, a price-to ... cinnamon tree restaurant hunt valley mdWebCorporate Controller, Principal Accounting Officer, & Treasurer at Ironwood Pharmaceuticals Greater Boston. 1K followers 500+ connections. Join to view profile Ironwood Pharmaceuticals ... dialecte wallonWebMar 5, 2024 · Ironwood Pharmaceuticals, headquartered in Boston, Massachusetts, and established in 1998, is a specialty and generic drug manufacturing company specializing … dialectes allemandsWebJul 22, 2024 · BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its second quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 5, 2024. Individuals interested in participating in the call should dial (833) 350-1432 (U.S. and Canada) or (647) 689-6932 … cinnamon tree poughkeepsie